Identification of Target Candidates for Pancreatic Adenocarcinoma Immunotherapy

Time: 9:30 am
day: Day Two


  • Miltenyi Biotec presents the MACSima Ultra-high content imaging platform
  • Learn how MICS technology enables you to visualize hundreds of markers from
    fixed tissue to lift your sample analysis to the next level
  • See a comprehensive workflow for the identification of new target candidates